Bitter with the sweet..
f plecanatide's advantage is backed up by a second phase 3 trial -- results from which are expected soon -- then Synergy could file for FDA approval this year and plecanatide could hit the market as early as late next year.
Should like the deal...
has no clothes. The greedy institutions screwed the little guy again..
Very sad for the retail crowd. Buy KMI was gushing on CNBC and Fox Business. Now you know why,
now has no clothes. Very sad as the retail crowd will mow be screwed. Don't believe me? Watch what happens..
This has upended the business model..
KMI was structured for a stable or increasing NGAS market. This decline is not over.
Backlog means squat in a declining commodity market
Brokers and Investment bankers were all over themselves pumping this to the retail crowd..
It was out of business months ago..
Seems so from my analysis..
Kinder Morgan is the largest energy infrastructure company in North America. It owns an interest in or operates approximately 84,000 miles of pipelines and 165 terminals. The company’s pipelines transport natural gas, gasoline, crude oil, CO2 and other products. Additionally, the company’s terminals store petroleum products and chemicals, and handle bulk materials like coal and petroleum coke. Kinder Morgan is the largest midstream and the third-largest energy company in North America with an enterprise value of more than $130 billion.
Currently, Kinder Morgan carries a Zacks Rank #3 (Hold). Better-ranked stocks from the same space include Enbridge Energy Partners L.P. EEP, EQT Midstream Partners L.P. EQM and Cheniere Energy, Inc. LNG. All these stocks sport a Zacks Rank #1 (Strong Buy).